Pharmacology Tool

Mechanism of Action Diagram Generator target to effect

Generate drug mechanism of action diagrams from text: target, binding, downstream effect, inhibition and activation arrows. For papers, grants and pitch decks.

Kinase inhibitors, blocking antibodies, ADCs, and degradersTarget, binding, and downstream effect layout

Create Your Mechanism of Action Diagram

Describe the drug mechanism
641 / 20,000 characters
Start from an example
AI-generated mechanism of action diagram of an EGFR tyrosine kinase inhibitor with and without the drugExample: Kinase inhibitorView full size

Free to try ·

Preview

Mechanism of Action Diagram Examples

Five AI drafts covering common drug mechanisms, each with the simplifications noted. Review before you publish.

View:

Kinase inhibitor: with and without the drug

AI-generated. Left and right panels compare normal EGFR signaling with ATP-pocket occupancy by the inhibitor. The order EGF, EGFR, RAS, RAF, MEK, ERK is right. Simplified: the adaptors GRB2 and SOS between the receptor and RAS are left out, and the drug is a generic icon, not a specific compound.

kinase inhibitorEGFRbefore and after

Checkpoint antibody blocking PD-1 and PD-L1

AI-generated. Without the antibody, PD-L1 on the tumor cell engages PD-1 and suppresses the T cell; with it, the interaction is blocked and the T cell can act. Simplified: one receptor pair, no co-stimulatory signals or antigen presentation.

antibodyPD-1immunotherapy

Enzyme inhibitor: statin and HMG-CoA reductase

AI-generated. Shows the rate-limiting step (HMG-CoA to mevalonate) and the downstream LDL receptor effect. The statin is the only inhibition symbol (T-bar, on the enzyme); the dashed HMG-CoA to mevalonate arrow shows reduced flux. Simplified: the many steps between mevalonate and cholesterol are collapsed into one arrow, and the LDL receptor is a schematic shape.

enzyme inhibitorstatinHMG-CoA reductase

Antibody-drug conjugate: five steps

AI-generated. Numbered steps run from antigen binding through endosome and lysosome to payload release and cell death. Simplified: the payload class is generic (DNA damage or microtubule disruption), and the endosome-to-lysosome maturation is drawn as a single fusion.

ADCinternalizationpayload

Targeted protein degrader (PROTAC)

AI-generated. Ternary complex, polyubiquitination, proteasome recognition, degradation, and catalytic recycling of the degrader. Simplified: the PROTAC is shown as a small bridge molecule, and its release before proteasome docking is not drawn separately.

PROTACdegraderubiquitin

Need the pathway the drug acts on? Start with the signaling pathway diagram generator, or see a worked example of a drug target pathway in the cGAS-STING pathway diagram generator.

What a mechanism of action diagram has to show

A mechanism of action (MoA) diagram shows how a drug produces its effect: which molecular target it engages, how it binds or modifies that target, and what changes downstream. Reviewers read it in a fixed order. They look for the target, the type of interaction (inhibition, activation, blockade, degradation), the cellular location, and the resulting cellular or tissue effect. A clear MoA figure separates molecular action from clinical outcome, so a binding event is never presented as an efficacy result.

Common drug mechanism archetypes

  • Enzyme or kinase inhibitor: the drug occupies an active site or ATP pocket and blocks catalysis, so the downstream cascade is reduced.
  • Receptor antagonist or agonist: the drug sits in the ligand pocket or an allosteric site and blocks, mimics, or modulates the natural ligand.
  • Blocking antibody: the antibody binds a receptor or ligand on the cell surface and prevents a pair interaction, as with PD-1 and PD-L1.
  • Antibody-drug conjugate: antigen binding, internalization, linker cleavage, payload release, cell death.
  • Targeted protein degrader: a bifunctional molecule brings an E3 ligase to the target, which is ubiquitinated and sent to the proteasome.
  • Prodrug: an inactive compound is converted to the active drug by a specific enzyme or condition before it acts.

How to write the prompt for a drug mechanism figure

  • Name the target and the drug class, for example "ATP-competitive EGFR tyrosine kinase inhibitor".
  • State the compartment: extracellular space, plasma membrane, cytoplasm, lysosome, nucleus.
  • Write the order of events as numbered steps, and say for each arrow whether it means binding, activation, inhibition, or translocation.
  • Ask for a before-and-after or with-and-without-drug layout when the point is what the drug changes.
  • Keep dose, efficacy numbers, and clinical claims out of the figure unless you add them yourself from a cited source.

Review every figure before you publish it

  • The generator gives a clean first draft with a sensible layout and legible labels. It does not guarantee pharmacology: it can swap an inhibition T-bar for an activation arrow, skip an intermediate step, or draw a protein in the wrong compartment.
  • Check the target name, the arrow meanings, and the order of steps against a primary source such as the original paper, a drug label, or a review before the figure goes into a manuscript, grant, or investor deck.
  • The gallery notes above list what each draft simplifies, so you can see what to fix.

Frequently Asked Questions